Novo invites you to join our Corporate-Supported Symposium in conjunction with ObesityWeek, November 14–17, 2026, in Washington, DC, USA.

Join us at ObesityWeek on Sunday, November 15, 2026 6:30–9 pm in Exhibit Hall A, Gaylord National Resort & Convention Center for an engaging symposium titled ‘Obesity in Focus: Today’s evidence. Tomorrow’s possibilities.’, exploring the evolving landscape of obesity management, followed by dinner from 7:45–9 pm.

Chaired by Dr. Jaime Almandoz (USA), this symposium will bring together expert faculty to discuss what is making headlines in obesity care. From the latest guideline recommendations and clinical evidence for approved pharmacological treatments to the emerging science of native amylin and amylin analogs, the program will combine focused presentations with expert commentary and discussion. Hear from Dr. Deborah Horn (USA) on what is changing in obesity guidelines, Dr. Akshay Jain (Canada) on the evidence shaping current pharmacological treatment, Prof. Thomas Lutz (Switzerland) on the biology and mechanism of action of amylin and its potential to complement GLP-1, and Dr. Domenica Rubino (USA) on emerging evidence for amylin analogs, including potential effects on weight management.

We look forward to seeing you for 75 minutes of expert insights, emerging evidence and discussion.